Chargement en cours...
Biologics as countermeasures for acute radiation syndrome: where are we now?
Despite significant scientific advances toward the development of a safe, nontoxic and effective radiation countermeasure for acute radiation syndrome (ARS) over the past six decades, no drug has been approved by the US FDA. Several biologics are currently under development as radiation countermeasu...
Enregistré dans:
| Publié dans: | Expert Opin Biol Ther |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Informa Healthcare
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4720033/ https://ncbi.nlm.nih.gov/pubmed/25416452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.986453 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|